Recently Released Market Study: Hereditary Angioedema (HAE) - Pipeline Review, H2 2012
Global Markets Direct's, 'Hereditary Angioedema (HAE) - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Hereditary Angioedema (HAE), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hereditary Angioedema (HAE). Hereditary Angioedema (HAE) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites,...
View full press release